the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma
A Multi-institution Real-world Study of the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma
A Multi-institution Real-world Study of the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma
Sponsor study identifier
observational
801
1 country
1
Study Start
January 1, 2008
Actual (reported)Primary Completion
December 1, 2016
Actual (reported)Study Completion
December 15, 2022
Actual (reported)Due to lacking of evidence on surveillance for gastric neuroendocrine carcinoma (G-NEC), this study aimed to determine the optimal postsurgical surveillance strategy for G-NEC patients and compare its cost-effectiveness with traditional surveillance strategies.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 15, 2022
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2008
Actual (reported)December 1, 2016
Actual (reported)December 15, 2022
Actual (reported)December 31, 2022
Actual (reported)January 4, 2023
Actual (reported)recurrence rate
distant, peritoneal, and local recurrence
60 months
Delayed-detection months
60 months
Incremental cost-effectiveness ratios (ICERs)
60 months
A total of 801 G-NEC patients from 21 centers in China were included.
Contact the study team to confirm eligibility.
Chang-ming Huang
Fuzhou, Fujian, 350001, China
Xu BB, He XY, Zhou YB, He QL, Tian YT, Hao HK, Qiu XT, Jiang LX, Zhao G, Li Z, Xu YC, Fu WH, Xue FQ, Li SL, Xu ZK, Zhu ZG, Li Y, Li E, Chen JP, Li HL, Cai LS, Wu D, Li P, Zheng CH, Xie JW, Lu J, Huang CM. Optimal postoperative surveillance strategies for cancer survivors with gastric neuroendocrine carcinoma based on individual risk: a multicenter real-world cohort study. Int J Surg. 2023 Jun 1;109(6):1668-1676. doi: 10.1097/JS9.0000000000000401.
Chang-ming Huang, MD
Fujian Medical University Union Hospital
801 participants (actual enrollment reported by the registry).
First Submitted
December 31, 2022
First Posted
January 4, 2023
Study Start
January 1, 2008
Actual (reported)Primary Completion
December 1, 2016
Actual (reported)Study Completion
December 15, 2022
Actual (reported)Last Updated
January 4, 2023
Record last verified: 2022-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: